Vanguard Group’s ABVC BioPharma ABVC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Buy |
111,533
+64,586
| +138% | +$144K | ﹤0.01% | 4053 |
|
|
2025
Q1 | $49.8K | Hold |
46,947
| – | – | ﹤0.01% | 4193 |
|
|
2024
Q4 | $27.7K | Hold |
46,947
| – | – | ﹤0.01% | 4244 |
|
|
2024
Q3 | $32.1K | Hold |
46,947
| – | – | ﹤0.01% | 4273 |
|
|
2024
Q2 | $36.3K | Hold |
46,947
| – | – | ﹤0.01% | 4312 |
|
|
2024
Q1 | $61.5K | Buy |
46,947
+19,700
| +72% | +$25.8K | ﹤0.01% | 4290 |
|
|
2023
Q4 | $31.6K | Buy |
27,247
+8,926
| +49% | +$10.4K | ﹤0.01% | 4411 |
|
|
2023
Q3 | $19.1K | Sell |
18,321
-369,192
| -95% | -$384K | ﹤0.01% | 4499 |
|
|
2023
Q2 | $201K | Hold |
387,513
| – | – | ﹤0.01% | 4315 |
|
|
2023
Q1 | $248K | Buy |
387,513
+12,000
| +3% | +$7.68K | ﹤0.01% | 4288 |
|
|
2022
Q4 | $235K | Buy |
375,513
+371
| +0.1% | +$232 | ﹤0.01% | 4279 |
|
|
2022
Q3 | $330K | Hold |
375,142
| – | – | ﹤0.01% | 4327 |
|
|
2022
Q2 | $398K | Hold |
375,142
| – | – | ﹤0.01% | 4340 |
|
|
2022
Q1 | $1.02M | Buy |
375,142
+2,382
| +0.6% | +$6.5K | ﹤0.01% | 4201 |
|
|
2021
Q4 | $1.26M | Buy |
372,760
+332,200
| +819% | +$1.13M | ﹤0.01% | 4197 |
|
|
2021
Q3 | $94K | Buy |
+40,560
| New | +$94K | ﹤0.01% | 4531 |
|